Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Drug Alcohol Depend. 2015 Dec 24;159:174–180. doi: 10.1016/j.drugalcdep.2015.12.013

Table 1.

Baseline characteristics of the participants stratified by binge drinking

Binge Drinking2
Total1 (N=255) Yes (N=57) No (N=198) p-value
Sex
 Male 127 (49.8%) 43 (33.9%) 84 (66.1%) <.001 (a)
 Female 128 (50.2%) 14 (10.9%) 114 (89.1%)
Age
 Mean (s.d.) 38.64 (10.01) 37.54 (8.35) 38.95 (10.44) 0.29 (b)
Site located in Haiti
 Yes 73 (28.6%) 18 (24.7%) 55 (75.3%) 0.58 (a)
 No 182 (71.4%) 39 (21.4%) 143 (78.6%)
Treatment Strategy
 mDOT 127 (49.8%) 31 (24.4%) 96 (75.6%) 0.43 (a)
 Standard of Care 128 (50.2%) 26 (20.3%) 102 (79.7%)
Years on cART before entry
 Median (Q1, Q3) 3.14 (1.98, 4.94) 2.97 (1.89, 4.56) 3.17 (2.04, 5.08) 0.22 (c)
CD4 Count (cells/mm3)
 Median (Q1, Q3) 175 (91, 271) 213 (112, 320) 169 (89, 263) 0.16 (c)
Viral load(log10(cp/mL)
 Median (Q1, Q3) 4.27 (3.77, 4.91) 4.23 (3.76, 4.84) 4.29 (3.79, 4.92) 0.53 (c)
* Any substance use last 30 days
 Yes 7 (2.7%) 6 (85.7%) 1 (14.3%) <.001 (d)
 No 248 (97.3%) 51 (20.6%) 197 (79.4%)
Self-perception of health
 Excellent, very good, good 193 (75.7%) 48 (24.9%) 145 (75.1%) 0.09 (a)
 Fair, poor 62 (24.3%) 9 (14.5%) 53 (85.5%)
(a)

Chi-Square Test;

(b)

T-Test with Unequal Variance;

(c)

Wilcoxon Rank Sum Test;

(d)

Fisher's Exact Test;

1

Column percent;

2

Row percent;

*

Other than alcohol;

cART=combination antiretroviral therapy; mDOT=modified directly observed therapy; (Q1–Q3)=Interquartile range; s.d.=standard deviation